Literature DB >> 7268

Commentary: Neuropharmacology of hypothalamic releasing factors.

N P Plotnikoff, A J Kastin.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 7268     DOI： 10.1016/0006-2952(76)90332-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.

Authors:  S Björkman; H Sievertsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

2.  Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.

Authors:  R B Rastogi; R L Singhal; Y D Lapierre
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  Effect of TRH on the central nervous system.

Authors:  A S Aslanov; G I Lavretskaya
Journal:  Neurosci Behav Physiol       Date:  1988 Mar-Apr

4.  Potentiation by TRH of the effect of antidepressants in the forced-swimming test, involvement of dopaminergic and opioid systems.

Authors:  V Reny-Palasse; M Constans; R Rips
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

5.  Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.

Authors:  S Chiu; R K Mishra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

6.  Potentiation by TRH of the effect of imipramine on the forced-swimming test.

Authors:  V Reny-Palasse; R Rips
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.